adenosine (redirected from adenosine diphosphate (ADP))

adenosine /aden·o·sine/ (ah-den´o-sēn) a purine nucleoside consisting of adenine and ribose; a component of RNA. It is also a cardiac depressant and vasodilator used as an antiarrhythmic and as an adjunct in myocardial perfusion imaging in patients incapable of exercising adequately to undergo an exercise stress test. Symbol A.

---

cyclic adenosine monophosphate  a cyclic nucleotide, adenosine 3′,5′-cyclic monophosphate, that serves as an intracellular, and sometimes extracellular, “second messenger” mediating the action of many peptide or amine hormones. Abbreviated 3, cAMP, and cyclic AMP.

adenosine diphosphate  (ADP) a nucleotide, the 5′-pyrophosphate of adenosine, involved in energy metabolism; it is produced by the hydrolysis of adenosine triphosphate (ATP) and converted back to ATP by the metabolic processes oxidative phosphorylation and substrate-level phosphorylation.

adenosine monophosphate  (AMP) adenylic acid; a nucleotide, the 5′-phosphate of adenosine, involved in energy metabolism and nucleotide synthesis.

adenosine triphosphate  (ATP) a nucleotide, the 5′-triphosphate of adenosine, involved in energy metabolism and required for RNA synthesis; it occurs in all cells and is used to store energy in the form of high-energy phosphate bonds. The free energy derived from its hydrolysis is used to drive metabolic reactions, to transport molecules against concentration gradients, and to produce mechanical motion.

---

a·den·o·sine (-dn-sn)

n.

A nucleoside that is a structural component of nucleic acids and the major molecular component of ADP, AMP, and ATP.

---

adenosine

[əden′əsin, -sēn]

a compound derived from nucleic acid, composed of adenine and a sugar, d-ribose. Adenosine is the major molecular component of the nucleotides adenosine diphosphate, adenosine monophosphate, and adenosine triphosphate and of the nucleic acids DNA and RNA. Also called adenine-d-ribose. See also adenosine phosphate.

---

adenosine (den´sēn´),

n a compound derived from nucleic acid, composed of adenine and a sugar, D-ribose. Major molecular component of nucleotides and the nucleic acids.

adenosine monophosphate (AMP),

n an ester, composed of adenine, D-ribose, and phosphoric acid, that affects energy release in work done by a muscle.

adenosine triphosphate (ATP),

n a compound consisting of the nucleotide adenosine attached through its ribose group to three phosphoric acid molecules. Stores energy in muscles, which is released when it is hydrolized to adenosine diphosphate.

Adenoviridae

n a family of unenveloped, 20-sided DNA viruses found in mammals (Mastadenovirus) and birds (Aviadenovirus). The human variety can cause a number of diseases, from conjunctivitis to urinary tract infection.

---

adenosine

one of the four bases that make up RNA and DNA containing the pentose sugar, 2-deoxy-d-ribose. Adenosine nucleotides are involved in the energy metabolism of all cells. Adenosine can be linked to a chain of one, two or three phosphate groups to form adenosine monophosphate (AMP), adenosine diphosphate (ADP) or adenosine triphosphate (ATP). The bond between the phosphate groups in ADP or the two bonds between the phosphate groups in ATP are called high-energy bonds because hydrolysis of a high-energy bond provides a large amount of free energy that can be used to drive other processes that would not otherwise occur spontaneously. The energy that is derived from the oxidation of carbohydrates, fats or proteins is used to synthesize ATP. The energy stored in ATP is then used directly or indirectly to drive all other cellular processes that require energy, of which there are four major types: (1) the transport of molecules and ions across cell membranes against concentration gradients, which maintains the internal environment of the cell and produces the membrane potential for the conduction of nerve impulses; (2) the contraction of muscle fibers and other fibers producing the motion of cells; (3) the synthesis of chemical compounds; (4) the synthesis of other high-energy compounds.

---

cyclic adenosine monophosphate (cyclic AMP, cAMP, 3′,5′-cAMP)

a cyclic nucleotide, adenosine 3′,5′-cyclic monophosphate, involved in the action of many hormones, including catecholamines, ACTH and vasopressin. The hormone (first message) binds to a specific β-receptor on the cell membrane of target cells. This activates an enzyme, adenylate cyclase, which produces cyclic AMP from ATP. Cyclic AMP acts as a second messenger activating other enzymes via covalent modulation within the cell.

adenosine deaminase

key enzyme in degradation pathway of adenosine; catalyzes the deamination of adenosine to inosine. Many cases of severe combined immunodeficiency syndrome in humans result from a heritable lack of adenosine deaminase.

adenosine diphosphate (ADP)

a nucleotide, adenosine 5′-pyrophosphate, produced by the hydrolysis of adenosine triphosphate (ATP). It is then converted back to ATP by oxidative, substrate or photosynthic phosphorylation. See also adp.

adenosine monophosphate (AMP)

a nucleotide, adenosine 5′-phosphate, involved in energy metabolism and nucleotide synthesis. Called also adenylic acid.

adenosine triphosphatase

a term used to refer to the enzymatic activity of certain intercellular processes that split ATP to form ADP and inorganic phosphate, when the energy released is not used for the synthesis of chemical compounds. Examples are the splitting of ATP in muscle contraction in myosin head-groups and the transport of ions across cell membranes. Called also ATPase.

adenosine triphosphatase test

used as a quantitative assay of the amount of avian leukosis virus in chicken tissues or tissue cultures. It depends on the virus's characteristic of carrying on its surface a phosphatase enzyme that dephosphorylates adenosine triphosphate.

adenosine triphosphate (ATP)

a nucleotide, adenosine 5′-triphosphate, occurring in all cells, where it stores energy in the form of high-energy phosphate bonds. Free energy of hydrolysis is supplied to drive metabolic reactions or to transport molecules against concentration gradients, when ATP is hydrolyzed to ADP and inorganic phosphate or to AMP and inorganic pyrophosphate. ATP is also used to produce high-energy phosphorylated intermediary metabolites, such as glucose-6-phosphate.

---

adenosine

Adenacor (UK), Adenocard, Adenoscan

Pharmacologic class: Endogenous nucleoside

Therapeutic class: Antiarrhythmic

Pregnancy risk category C

Action

Converts paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm by slowing conduction through atrioventricular (AV) node and interrupting reentry pathway. Also used as a diagnostic agent in thallium scanning.

Availability

Injection: 3 mg/ml

⊘Indications and dosages

Adenocard -

➣ PSVT, including that associated with Wolff-Parkinson-White syndrome (after attempting vagal maneuvers, when appropriate)

Adults and children weighing more than 50 kg (110 lb): Initially, 6 mg by rapid I.V. bolus over 1 to 2 seconds. If desired effect isn't achieved within 1 to 2 minutes, give 12 mg by rapid I.V. bolus; may repeat 12-mg I.V. bolus dose as needed. Maximum single dosage is 12 mg.

Children weighing less than 50 kg (110 lb): 0.05 to 0.1 mg/kg by rapid I.V. bolus. If this dosage proves ineffective, increase in 1 to 2 minutes by 0.05 mg/kg q 2 minutes, to a maximum single dosage of 0.3 mg/kg. Maximum single dosage is 12 mg.

Adenoscan -

➣ Diagnosis of coronary artery disease in conjunction with thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately during testing

Adults: 140 mcg/kg/minute by I.V. infusion over 6 minutes, for a total dosage of 0.84 mg/kg. Required dose of thallium-201 is injected at midpoint (after first 3 minutes) of Adenoscan infusion.

Off-label uses

• Diagnosis of supraventricular arrhythmias
• Pulmonary hypertension

Contraindications

• Hypersensitivity to drug
• Second- or third-degree AV block
• Sinus node disease
• Bronchoconstrictive lung disease

Precautions

Use cautiously in:
• asthma, angina
• elderly patients
• pregnant patients
• children.

Administration

• Don't administer through central line (may cause asystole).
• Don't give more than 12 mg Adenocard as a single dose.
• Don't dilute Adenocard. Administer Adenocard by I.V. injection as a rapid bolus directly into vein whenever possible during cardiac monitoring.
• After administering Adenocard, flush I.V. line immediately and rapidly with normal saline solution to drive drug into bloodstream.
• Dilute a single dose of Adenoscan in sufficient normal saline solution to be given by continuous infusion over 6 minutes.

Route	Onset	Peak	Duration
I.V.	Immediate	10 sec	20-30 sec

Adverse reactions

CNS: light-headedness, dizziness, apprehension, headache, tingling in arms, numbness

CV: chest pain, palpitations, hypotension, ST-segment depression, first- or second-degree AV block, atrial tachyarrhythmias, other arrhythmias

EENT: blurred vision, tightness in throat

GI: nausea, pressure in groin

Musculoskeletal: discomfort in neck, jaw, and arms

Respiratory: chest pressure, dyspnea and urge to breathe deeply, hyperventilation

Skin: burning sensation, facial flushing, sweating

Other: metallic taste

Interactions

Drug-drug. Carbamazepine: worsening of progressive heart block

Digoxin, verapamil: increased risk of ventricular fibrillation

Dipyridamole: increased adenosine effect

Theophylline: decreased adenosine effect

Drug-food. Caffeine: decreased adenosine effect

Drug-herbs. Aloe, buckthorn bark or berry, cascara sagrada, rhubarb root, senna leaf or fruits: increased adenosine effect

Guarana: decreased adenosine effect

Drug-behaviors. Smoking: increased risk of tachycardia

Patient monitoring

• Monitor heart rhythm for new arrhythmias after administering dose.
• Check vital signs. Assess for chest pain or pressure, dyspnea, and sweating.
☞ Watch for bronchoconstriction in patients with asthma, emphysema, or bronchitis.
• Ask patient if he has recently used aloe, buckthorn, cascara sagrada, guarana, rhubarb root, or senna. If response is positive, notify prescriber.

Patient teaching

• Advise patient to report problems at infusion site.
• Tell patient he may experience 1 to 2 minutes of flushing, chest pain and pressure, and breathing difficulty during administration. Assure him that these effects will subside quickly.
• Advise patient to minimize GI upset by eating small, frequent servings of healthy food and drinking plenty of fluids.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, foods, herbs, and behaviors mentioned above.

---

adenosine

Cardiology An endogenous nucleoside composed of adenine linked to d-ribose, which results from the hydrolysis of adenylic acid; adenosine is a therapeutic alternative to verapamil, in treating both narrow- and wide-complex SVT; it ↓ heart rate, followed by a reflex ↑ in sinus discharge. See Calcium-channel blocker, Supraventricular tachycardia.